Main Menu

Alexion Pharmaceuticals, Inc.


Rigrodsky Law, P.A. is investigating Alexion Pharmaceuticals, Inc. (“Alexion”) regarding possible breaches of fiduciary duties and other violations of law related to Alexion’s agreement to be acquired by AstraZeneca PLC ("AstraZeneca").  Under the terms of the agreement, Alexion's shareholders will receive 2.1243 American Depository Shares of AstraZeneca and $60.00 in cash per share.

Join This Action

Alternatively, you may upload your transactions using the upload button below or email them to

Draw your signature below using your mouse* [Clear]

Signed pursuant to California Civil Code Section 1633.1, et seq. - and the Uniform Electronic Transactions Act as adopted by the various states and territories of the United States.

Date of signing: 04/13/2021

* Indicates a required field.

Back to Page